Summit Creek Advisors LLC Makes New $7.60 Million Investment in HealthEquity, Inc. $HQY

Summit Creek Advisors LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 84,157 shares of the company’s stock, valued at approximately $7,601,000. HealthEquity makes up approximately 2.6% of Summit Creek Advisors LLC’s investment portfolio, making the stock its 9th largest position. Summit Creek Advisors LLC owned 0.10% of HealthEquity at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Acumen Wealth Advisors LLC bought a new position in HealthEquity in the 4th quarter worth approximately $27,000. Caitong International Asset Management Co. Ltd boosted its holdings in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares during the period. Aster Capital Management DIFC Ltd purchased a new position in shares of HealthEquity in the fourth quarter valued at $28,000. Leonteq Securities AG raised its stake in shares of HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after purchasing an additional 235 shares during the period. Finally, Axiom Investment Management LLC purchased a new stake in HealthEquity during the 1st quarter worth about $33,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HealthEquity stock opened at $102.79 on Wednesday. The firm has a market capitalization of $8.59 billion, a PE ratio of 38.50, a price-to-earnings-growth ratio of 1.76 and a beta of 0.21. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $107.62. The business’s 50-day moving average price is $95.71 and its 200-day moving average price is $86.80.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on HQY shares. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Citizens Jmp boosted their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research note on Monday, June 1st. Barrington Research reaffirmed an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Finally, BTIG Research boosted their price target on shares of HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $110.93.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the company’s stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the transaction, the executive vice president owned 52,244 shares in the company, valued at approximately $4,963,180. This represents a 4.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares of the company’s stock, valued at $1,775,970. This represents a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock worth $1,651,280 over the last quarter. Corporate insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.